Tag: intravenous iv fluid transfer drug devices market

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

#Intravenous Fluid Transfer Drug Devices Market CAGR Outlook And Future Development#_x000D_

The intravenous fluid transfer drug devices market has demonstrated significant expansion in recent years. The market’s value is expected to rise from $7.85 billion in 2025 to $8.35 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.3%. This past growth can be ascribed to several factors, including the widespread reliance on conventional IV sets, an increase in hospital and clinical procedures, the restricted availability of smart infusion devices, heightened awareness regarding the advantages of IV therapy, and the adoption of PVC infusion bags._x000D_

_x000D_

The intravenous fluid transfer drug devices market is projected to demonstrate robust expansion over the next few years. It is forecast to grow to $10.55 billion in 2030, achieving a compound annual growth rate (CAGR) of 6.0%. The anticipated growth during this period stems from various factors, including technological advancements in smart infusion pumps, an increasing demand for pre-filled and multi-chamber infusion bags, wider applications in oncology and neurology, the expansion of home healthcare and ambulatory infusion services, and more stringent regulatory and quality standards. Significant trends expected in the forecast period encompass a rising adoption of smart infusion devices and pumps, an increasing use of pre-filled and multi-chamber infusion bags, growing demand for needleless connectors and safety IV sets, the expansion of IV therapy across chronic and critical care treatments, and an enhanced focus on sterility, accuracy, and flow control._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=84913125&type=smp&name=Intravenous%20Fluid%20Transfer%20Drug%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Intravenous Fluid Transfer Drug Devices Market Opportunity Drivers: What’s Unlocking New Revenue Potential?#_x000D_

An increasing hospitalization rate is anticipated to fuel the expansion of the intravenous fluid transfer drug device market in the future. This rise in hospitalizations is attributed to an aging population, chronic illnesses, advanced diagnostics, and increased healthcare access, alongside lifestyle-related diseases and medical technology advancements. Fluid transfer systems enable the precise and controlled administration of fluids and medications directly into the bloodstream for hospitalized patients. For instance, in March 2023, according to GOV.UK, a US-based government agency, COVID-19 hospital admissions in England in 2023 saw a slight rise to 10.62 per 100,000, while ICU/HDU admissions stayed low at 0.28 per 100,000. Most regions observed minor increases, with rates remaining largely stable across age groups. Consequently, an upward trend in hospitalization rates will be a significant driver for the intravenous fluid transfer drug device market growth._x000D_

_x000D_

#Intravenous Fluid Transfer Drug Devices Market Segmentation And Category Overview#_x000D_

The intravenous fluid transfer drug devices market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Infusion Bags, Infusion Devices, Other Types_x000D_

2) By Application: Autoimmune Diseases, Blood Disorders, Cardiovascular Disorders, Neurology, Oncology, Other Applications_x000D_

3) By End-Use Sector: Hospitals, Specialized Clinics, Other End-Use Sectors_x000D_

_x000D_

Subsegments:_x000D_

1) By Infusion Bags: PVC Infusion Bags, Non-PVC Infusion Bags, Pre-Filled Infusion Bags, Multi-Chamber Infusion Bags, IV Fluid Administration Bags _x000D_

2) By Infusion Devices: Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Gravity Infusion Devices, Smart Infusion Devices _x000D_

3) By Other Types: IV Sets And Accessories, IV Catheters, Needleless Connectors, Flow Regulators, Pressure Infusion Devices_x000D_

_x000D_

#Intravenous Fluid Transfer Drug Devices Market Innovation Trends Shaping Future Development#_x000D_

Leading companies in the intravenous fluid transfer drug device market are actively developing modular and comprehensive infusion systems. These systems integrate features like auto-identification to enhance precision, boost patient safety, and streamline the delivery of fluids and medications. Auto-identification within infusion systems functions by automatically verifying and matching medications to the correct patient through the use of barcode scanning or RFID technology. For example, in July 2023, Becton, Dickinson, and Company, a US-based medical device company, obtained FDA 510(k) clearance for its upgraded BD Alaris Infusion System. This BD Alaris Infusion System features updated hardware for its Point-of-Care Unit (PCU), which includes large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, and auto-identification modules. Additionally, it introduces an advanced software version with improved cybersecurity and interoperability features, enabling seamless integration with widely adopted electronic medical record (EMR) systems, thereby supporting smart and connected healthcare initiatives._x000D_

_x000D_

#Intravenous Fluid Transfer Drug Devices Market Top Companies Driving Competitive Growth#_x000D_

Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Baxter International Inc., B Braun Holding GmbH Co KG, Fresenius Kabi AG, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Arcomed AG, Terumo Corporation, Smiths Medical, IRadimed Corporation, Micrel Medical Devices SA, Boston Scientific Corporation, AdvaCare Pharma, Eitan Medical, Ypsomed Holding AG _x000D_

_x000D_

#View The Full Intravenous Fluid Transfer Drug Devices Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/intravenous-fluid-transfer-drug-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Intravenous Fluid Transfer Drug Devices Market Global Footprint: Which Region Leads The Market?#_x000D_

North America was the largest region in the intravenous fluid transfer drug devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Market Value Of The Intravenous Fluid Transfer Drug Devices Market Projected To Expand During 2026–2030?

The intravenous fluid transfer drug devices market has experienced robust growth recently. It is projected to expand from $7.85 billion in 2025 to $8.35 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 6.3%. Historically, this growth can be attributed to factors such as the continued reliance on conventional IV sets, the rise in hospital and clinical procedures, the restricted availability of smart infusion devices, increasing understanding of IV therapy advantages, and the adoption of PVC infusion bags.

The intravenous fluid transfer drug devices market is anticipated to experience substantial growth in the coming years. It is projected to reach $10.55 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. This expansion during the forecast period can be attributed to several factors, including ongoing technological advancements in smart infusion pumps, a growing need for pre-filled and multi-chamber infusion bags, increased applications within oncology and neurology, the expansion of home healthcare and ambulatory infusion services, and more stringent regulatory and quality standards. Key trends expected over the forecast period include the increasing adoption of smart infusion devices and pumps, greater utilization of pre-filled and multi-chamber infusion bags, a rising demand for needleless connectors and safety IV sets, the broader application of IV therapy in chronic and critical care treatments, and a heightened emphasis on sterility, accuracy, and flow control.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19535&type=smp

Which Growth Drivers Are Expected To Support The Intravenous Fluid Transfer Drug Devices Market Forward?

An increasing rate of hospitalizations is projected to stimulate the expansion of the intravenous fluid transfer drug device market moving forward. This rise in hospitalization rates is attributed to an aging population, the prevalence of chronic illnesses, advancements in diagnostics, and improved access to healthcare, alongside lifestyle-related diseases and progress in medical technology. Fluid transfer systems are essential for the precise and controlled delivery of fluids and medications directly into the bloodstream of patients admitted to hospitals. For instance, according to GOV.UK, a US-based government agency, by March 2023, COVID-19 hospital admissions in England had slightly increased to 10.62 per 100,000 in 2023, while ICU/HDU admissions remained low at 0.28 per 100,000. Most regions experienced minor increases, with rates largely stable across various age groups. Therefore, an escalating hospitalization rate is expected to propel the growth of the intravenous fluid transfer drug device market.

What Are The Major Segment Categories Within The Intravenous Fluid Transfer Drug Devices Market?

The intravenous fluid transfer drug devices market covered in this report is segmented –

1) By Type: Infusion Bags, Infusion Devices, Other Types

2) By Application: Autoimmune Diseases, Blood Disorders, Cardiovascular Disorders, Neurology, Oncology, Other Applications

3) By End-Use Sector: Hospitals, Specialized Clinics, Other End-Use Sectors

Subsegments:

1) By Infusion Bags: PVC Infusion Bags, Non-PVC Infusion Bags, Pre-Filled Infusion Bags, Multi-Chamber Infusion Bags, IV Fluid Administration Bags

2) By Infusion Devices: Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Gravity Infusion Devices, Smart Infusion Devices

3) By Other Types: IV Sets And Accessories, IV Catheters, Needleless Connectors, Flow Regulators, Pressure Infusion Devices

What Trends Are Affecting The Growth Of The Intravenous Fluid Transfer Drug Devices Market?

Major companies operating within the intravenous fluid transfer drug device market are creating modular and extensive infusion systems equipped with functionalities like auto-identification. These systems are designed to improve precision, bolster patient safety, and simplify the administration of fluids and medications. Auto-identification in infusion systems works by automatically confirming and matching medications to the appropriate patient, utilizing either barcode scanning or RFID technology. For instance, in July 2023, Becton, Dickinson, and Company, a US-based medical device firm, received FDA 510(k) clearance for its updated BD Alaris Infusion System. The BD Alaris Infusion System features upgraded hardware for its Point-of-Care Unit (PCU), which encompasses large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, and auto-identification modules. Furthermore, it introduces an advanced software version that offers enhanced cybersecurity and interoperability, allowing for smooth integration with commonly used electronic medical record (EMR) systems, thereby supporting smart and interconnected healthcare.

Which Organizations Are Involved In The Intravenous Fluid Transfer Drug Devices Market?

Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Baxter International Inc., B Braun Holding GmbH Co KG, Fresenius Kabi AG, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Arcomed AG, Terumo Corporation, Smiths Medical, IRadimed Corporation, Micrel Medical Devices SA, Boston Scientific Corporation, AdvaCare Pharma, Eitan Medical, Ypsomed Holding AG

Access The Complete Intravenous Fluid Transfer Drug Devices Market Report:

https://www.thebusinessresearchcompany.com/report/intravenous-fluid-transfer-drug-devices-global-market-report

Which Region Stands As The Largest Contributor To The Intravenous Fluid Transfer Drug Devices Market?

North America was the largest region in the intravenous fluid transfer drug devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Intravenous Fluid Transfer Drug Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/intravenous-fluid-transfer-drug-devices-global-market-report

Browse Through More Reports Similar to the Global Intravenous Fluid Transfer Drug Devices Market 2026, By The Business Research Company

Neurovascular Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurovascular-catheters-global-market-report

Peripheral Iv Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-iv-catheters-global-market-report

Central Venous Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/central-venous-catheters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Intravenous Fluid Transfer Drug Devices Market Between 2026 And 2030?

The intravenous fluid transfer drug devices market has experienced substantial growth in recent years. It is projected to expand from $7.85 billion in 2025 to $8.35 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.3%. This historical growth can be attributed to factors such as reliance on conventional iv sets, increasing hospital and clinical procedures, limited availability of smart infusion devices, growing awareness of iv therapy benefits, and adoption of pvc infusion bags.

The market for intravenous fluid transfer drug devices is projected to experience substantial expansion in the coming years. This market is anticipated to reach $10.55 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.0%. This projected growth is driven by several factors, including technological advancements in smart infusion pumps, increased demand for pre-filled and multi-chamber infusion bags, broader applications in oncology and neurology, the expansion of home healthcare and ambulatory infusion services, and more stringent regulatory and quality standards. Key trends expected during this period involve the growing acceptance of smart infusion devices and pumps, greater utilization of pre-filled and multi-chamber infusion bags, a rise in the need for needleless connectors and safety IV sets, the broadened application of IV therapy in chronic and critical care, and an increased emphasis on sterility, accuracy, and flow control.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/intravenous-fluid-transfer-drug-devices-global-market-report

Which Strong Drivers Are Impacting The Intravenous Fluid Transfer Drug Devices Market Growth?

The intravenous fluid transfer drug device market is anticipated to expand due to an increase in hospitalization rates in the future. This increase in hospitalizations is influenced by an aging demographic, the prevalence of chronic illnesses, improved diagnostic capabilities, and greater access to healthcare, along with lifestyle-associated diseases and breakthroughs in medical technology. Fluid transfer systems play a crucial role in ensuring the accurate and regulated delivery of fluids and medications straight into the bloodstream of patients admitted to hospitals. As an illustration, data from GOV.UK, a US-based government agency, indicated that in March 2023, COVID-19 hospital admissions in England showed a slight increase to 10.62 per 100,000 in 2023, whereas ICU/HDU admissions remained low at 0.28 per 100,000. Minor rises were observed across most regions, with admission rates generally consistent across various age demographics. Consequently, an escalating hospitalization rate is poised to boost the growth of the intravenous fluid transfer drug device market.

How Is Segmentation Applied In The Intravenous Fluid Transfer Drug Devices Market Segment Analysis?

The intravenous fluid transfer drug devices market covered in this report is segmented –

1) By Type: Infusion Bags, Infusion Devices, Other Types

2) By Application: Autoimmune Diseases, Blood Disorders, Cardiovascular Disorders, Neurology, Oncology, Other Applications

3) By End-Use Sector: Hospitals, Specialized Clinics, Other End-Use Sectors

Subsegments:

1) By Infusion Bags: PVC Infusion Bags, Non-PVC Infusion Bags, Pre-Filled Infusion Bags, Multi-Chamber Infusion Bags, IV Fluid Administration Bags

2) By Infusion Devices: Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Gravity Infusion Devices, Smart Infusion Devices

3) By Other Types: IV Sets And Accessories, IV Catheters, Needleless Connectors, Flow Regulators, Pressure Infusion Devices

Which Trends Are Contributing To Changes In The Intravenous Fluid Transfer Drug Devices Market?

Leading companies within the intravenous fluid transfer drug device market are actively developing modular and comprehensive infusion systems. These systems integrate features like auto-identification, aiming to boost accuracy, enhance patient safety, and streamline the process of administering fluids and medications. Auto-identification in infusion systems functions by automatically verifying and matching medications to the correct patient, typically utilizing barcode scanning or RFID technology. For instance, in July 2023, Becton, Dickinson, and Company, a US-based medical device company, obtained FDA 510(k) clearance for its updated BD Alaris Infusion System. The BD Alaris Infusion System includes refreshed hardware for its Point-of-Care Unit (PCU), featuring large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, and auto-identification modules. It also introduces an advanced software version with improved cybersecurity and interoperability features, allowing for seamless integration with widely used electronic medical record (EMR) systems, thereby supporting smart and connected healthcare.

Who Are The Companies Participating In The Intravenous Fluid Transfer Drug Devices Market Environment?

Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Baxter International Inc., B Braun Holding GmbH Co KG, Fresenius Kabi AG, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Arcomed AG, Terumo Corporation, Smiths Medical, IRadimed Corporation, Micrel Medical Devices SA, Boston Scientific Corporation, AdvaCare Pharma, Eitan Medical, Ypsomed Holding AG

Get The Full Intravenous Fluid Transfer Drug Devices Market Report:

https://www.thebusinessresearchcompany.com/report/intravenous-fluid-transfer-drug-devices-global-market-report

Where Is The Intravenous Fluid Transfer Drug Devices Market Primarily Concentrated By Region?

North America was the largest region in the intravenous fluid transfer drug devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Intravenous Fluid Transfer Drug Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/intravenous-fluid-transfer-drug-devices-global-market-report

Browse Through More Reports Similar to the Global Intravenous Fluid Transfer Drug Devices Market 2026, By The Business Research Company

Neurovascular Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurovascular-catheters-global-market-report

Peripheral Iv Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-iv-catheters-global-market-report

Central Venous Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/central-venous-catheters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Intravenous Fluid Transfer Drug Devices Market By The End Of 2030?

The intravenous fluid transfer drug devices market size has seen robust growth in recent years. It is projected to increase from $7.85 billion in 2025 to $8.35 billion in 2026, progressing at a compound annual growth rate (CAGR) of 6.3%. The expansion observed in the historic period can be attributed to a reliance on conventional IV sets, an increase in hospital and clinical procedures, the limited availability of smart infusion devices, growing awareness of IV therapy benefits, and the adoption of PVC infusion bags.

The intravenous fluid transfer drug devices market is anticipated to show robust expansion over the next few years. It is expected to reach **$10.55 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%.** This growth during the forecast period can be attributed to several factors including technological advancements in smart infusion pumps, a rising demand for pre-filled and multi-chamber infusion bags, increasing applications in oncology and neurology, the growth of home healthcare and ambulatory infusion, and stricter regulatory and quality standards. Major trends expected during this period include the rising adoption of smart infusion devices and pumps, increasing use of pre-filled and multi-chamber infusion bags, growing demand for needleless connectors and safety IV sets, the expansion of IV therapy across chronic and critical care treatments, and an enhanced focus on sterility, accuracy, and flow control.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19535&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Intravenous Fluid Transfer Drug Devices Market?

A projected increase in hospitalization rates is anticipated to fuel the expansion of the intravenous fluid transfer drug device market in the future. This surge in hospitalizations stems from factors such as an aging demographic, prevalent chronic conditions, sophisticated diagnostic tools, greater access to healthcare, as well as lifestyle-related health issues and progress in medical technology. For patients admitted to hospitals, fluid transfer systems facilitate the accurate and regulated delivery of fluids and medicines directly into their bloodstream. As an illustration, data from GOV.UK, a US-based government agency, indicated that in March 2023, COVID-19 hospital admissions within England saw a minor increase, reaching 10.62 per 100,000 in 2023, while ICU/HDU admissions remained minimal at 0.28 per 100,000. Most areas experienced modest rises, with admission rates generally consistent across various age demographics. Consequently, an elevated hospitalization rate is set to stimulate the growth of the intravenous fluid transfer drug device market.

Which Segment Classifications Shape The Intravenous Fluid Transfer Drug Devices Market?

The intravenous fluid transfer drug devices market covered in this report is segmented –

1) By Type: Infusion Bags, Infusion Devices, Other Types

2) By Application: Autoimmune Diseases, Blood Disorders, Cardiovascular Disorders, Neurology, Oncology, Other Applications

3) By End-Use Sector: Hospitals, Specialized Clinics, Other End-Use Sectors

Subsegments:

1) By Infusion Bags: PVC Infusion Bags, Non-PVC Infusion Bags, Pre-Filled Infusion Bags, Multi-Chamber Infusion Bags, IV Fluid Administration Bags

2) By Infusion Devices: Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Gravity Infusion Devices, Smart Infusion Devices

3) By Other Types: IV Sets And Accessories, IV Catheters, Needleless Connectors, Flow Regulators, Pressure Infusion Devices

How Are Trends Impacting The Intravenous Fluid Transfer Drug Devices Market?

Major companies in the intravenous fluid transfer drug device market are actively developing modular and comprehensive infusion systems, incorporating features such as auto-identification to enhance accuracy, improve patient safety, and streamline the administration of fluids and medications. Auto-identification within these infusion systems functions by automatically verifying and matching medications to the correct patient, utilizing technologies such as barcode scanning or RFID. An instance of this progress is Becton, Dickinson, and Company, a US-based medical device company, which received FDA 510(k) clearance in July 2023 for its updated BD Alaris Infusion System. The BD Alaris Infusion System features updated hardware for its Point-of-Care Unit (PCU), including large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, and auto-identification modules. Additionally, it introduces an advanced software version with enhanced cybersecurity and interoperability features, enabling seamless integration with widely used electronic medical record (EMR) systems, thereby fostering smart and connected healthcare.

Which Companies Are Expanding Their Footprint In The Intravenous Fluid Transfer Drug Devices Market?

Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Baxter International Inc., B Braun Holding GmbH Co KG, Fresenius Kabi AG, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Arcomed AG, Terumo Corporation, Smiths Medical, IRadimed Corporation, Micrel Medical Devices SA, Boston Scientific Corporation, AdvaCare Pharma, Eitan Medical, Ypsomed Holding AG

Read the full intravenous fluid transfer drug devices market report here:

https://www.thebusinessresearchcompany.com/report/intravenous-fluid-transfer-drug-devices-global-market-report

Which Regions Are Projected To Dominate The Intravenous Fluid Transfer Drug Devices Market In The Coming Years?

North America was the largest region in the intravenous fluid transfer drug devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Intravenous Fluid Transfer Drug Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19535&type=smp

Browse Through More Reports Similar to the Global Intravenous Fluid Transfer Drug Devices Market 2026, By The Business Research Company

Neurovascular Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurovascular-catheters-global-market-report

Peripheral Iv Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-iv-catheters-global-market-report

Central Venous Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/central-venous-catheters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Intravenous Fluid Transfer Drug Devices Market’s size between 2026 and 2030?

The market for intravenous fluid transfer drug devices has experienced substantial expansion in recent years. This market is projected to expand from $7.85 billion in 2025 to reach $8.35 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 6.3%. The historical growth can be linked to factors such as dependence on conventional IV sets, an increase in hospital and clinical procedures, the restricted supply of smart infusion devices, growing awareness regarding the benefits of IV therapy, and the adoption of PVC infusion bags.

The intravenous fluid transfer drug devices market size is projected to experience robust growth over the next few years. It is expected to expand to $10.55 billion by 2030, achieving a compound annual growth rate (CAGR) of 6.0%. This anticipated growth can be attributed to several factors including technological advancements in smart infusion pumps, an increasing demand for pre-filled and multi-chamber infusion bags, expanding applications in oncology and neurology, the rise of home healthcare and ambulatory infusion, and more rigorous regulatory and quality standards. Significant trends during the forecast period involve the rising adoption of smart infusion devices and pumps, greater utilization of pre-filled and multi-chamber infusion bags, a growing need for needleless connectors and safety IV sets, the expansion of IV therapy across chronic and critical care treatments, and an enhanced focus on sterility, accuracy, and flow control.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19535&type=smp

Which Drivers Are Shaping Strategic Decisions In The Intravenous Fluid Transfer Drug Devices Market?

The increasing rate of hospitalizations is projected to drive the expansion of the intravenous fluid transfer drug device market in the future. This surge in hospitalization is fueled by factors such as an aging population, the prevalence of chronic illnesses, advancements in diagnostics, and improved healthcare access, in addition to lifestyle-related health issues and progress in medical technology. These fluid transfer systems facilitate the accurate and regulated delivery of both fluids and medications directly into the bloodstream for patients admitted to hospitals. For instance, in March 2023, GOV.UK, a US-based government agency, reported that in 2023, COVID-19 hospital admissions in England slightly increased to 10.62 per 100,000, while ICU/HDU admissions stayed low at 0.28 per 100,000. A majority of regions observed modest rises, and the rates largely remained consistent across various age demographics. Consequently, an escalating hospitalization rate is poised to stimulate the growth of the intravenous fluid transfer drug device market.

What Segment Classifications Make Up The Intravenous Fluid Transfer Drug Devices Market?

The intravenous fluid transfer drug devices market covered in this report is segmented –

1) By Type: Infusion Bags, Infusion Devices, Other Types

2) By Application: Autoimmune Diseases, Blood Disorders, Cardiovascular Disorders, Neurology, Oncology, Other Applications

3) By End-Use Sector: Hospitals, Specialized Clinics, Other End-Use Sectors

Subsegments:

1) By Infusion Bags: PVC Infusion Bags, Non-PVC Infusion Bags, Pre-Filled Infusion Bags, Multi-Chamber Infusion Bags, IV Fluid Administration Bags

2) By Infusion Devices: Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Gravity Infusion Devices, Smart Infusion Devices

3) By Other Types: IV Sets And Accessories, IV Catheters, Needleless Connectors, Flow Regulators, Pressure Infusion Devices

How Are Emerging Trends Affecting The Progression Of The Intravenous Fluid Transfer Drug Devices Market?

Leading enterprises in the intravenous fluid transfer drug device market are developing modular and integrated infusion systems that include features like auto-identification to improve accuracy, boost patient safety, and streamline the dispensing of fluids and medications. Auto-identification in infusion systems automatically confirms and aligns medications with the correct patient through barcode scanning or RFID technology. For instance, in July 2023, Becton, Dickinson, and Company, a US-based medical device company, secured FDA 510(k) clearance for its enhanced BD Alaris Infusion System. The BD Alaris Infusion System incorporates updated hardware for its Point-of-Care Unit (PCU), comprising large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, and auto-identification modules. It also introduces an advanced software version with bolstered cybersecurity and interoperability capabilities that permit smooth integration with widely used electronic medical record (EMR) systems, thereby supporting intelligent and connected healthcare.

Which Leading Companies Dominate The Intravenous Fluid Transfer Drug Devices Market Share?

Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Baxter International Inc., B Braun Holding GmbH Co KG, Fresenius Kabi AG, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Arcomed AG, Terumo Corporation, Smiths Medical, IRadimed Corporation, Micrel Medical Devices SA, Boston Scientific Corporation, AdvaCare Pharma, Eitan Medical, Ypsomed Holding AG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/intravenous-fluid-transfer-drug-devices-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Intravenous Fluid Transfer Drug Devices Market?

North America was the largest region in the intravenous fluid transfer drug devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Intravenous Fluid Transfer Drug Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19535&type=smp

Browse Through More Reports Similar to the Global Intravenous Fluid Transfer Drug Devices Market 2026, By The Business Research Company

Neurovascular Catheters Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurovascular-catheters-global-market-report

Peripheral Iv Catheters Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-iv-catheters-global-market-report

Central Venous Catheters Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/central-venous-catheters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Intravenous Fluid Transfer Drug Devices Market Size Shifted, And What Is the Outlook Through 2034?

The market for drug devices used in intravenous fluid transfer has seen robust growth in recent years. The market is projected to expand from $7.38 billion in 2024 to $7.85 billion in 2025, following a compound annual growth rate (CAGR) of 6.4%. The rise in the historical period is due to factors such as heightened demand for effective medical supplies, the expansion of healthcare infrastructure, an increase in surgical procedures needing IV support, policy modifications, enhancement in healthcare facilities, and the introduction of new drugs that require accurate administration.

How Much Will the Intravenous Fluid Transfer Drug Devices Market Be Worth in 2029?

The market for intravenous fluid transfer drug devices is projected to experience robust growth in the coming years, reaching a value of $9.96 billion by 2029 with a compound annual growth rate (CAGR) of 6.1%. The anticipated growth during this forecast period may be linked to a rise in demand for mobile devices, increased expenditure on state-of-the-art medical equipment, a surge in the need for reasonably priced healthcare options, and a growth in non-hospital treatment environments. Key trends expected during this forecast period comprise the incorporation of smart technologies, the implementation of automated IV fluid transfer systems, enhancements in safety features to curtail medication errors, and the use of devices that are compatible with remote monitoring services.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19535&type=smp

Which is the Largest Company in the Intravenous Fluid Transfer Drug Devices Market?

Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., 3M Company, Medtronic plc, Becton, Dickinson and Company, Baxter International Inc., B. Braun Holding GmbH & Co. KG, Fresenius Kabi AG, Mindray Medical International Limited, Nipro Corporation, Moog Inc., West Pharmaceutical Services Inc., ICU Medical Inc., Insulet Corporation, Merit Medical Systems Inc., Avanos Medical Inc., Vygon SAS, NxStage Medical Inc., AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Zyno Medical LLC, Sippex, Arcomed AG

What Are the Main Market Drivers in the Intravenous Fluid Transfer Drug Devices Industry?

The intravenous fluid transfer drug device market is set to expand due to increasing hospitalization rates. Factors such as an aging population, chronic diseases, improved diagnostics, broader access to healthcare, as well as lifestyle-related diseases and advancements in medical technology, are driving these surging rates of hospitalization. In order to deliver fluids and medications in a controlled and precise manner to the patients’ bloodstream, the use of fluid transfer systems is necessary. For instance, a report released by the American Hospital Association (AHA), confirmed that the total admissions in all American hospitals in May 2023 amounted to 34,011,386. This was a noticeable increase from the 33,356,853 admissions recorded in 2022. Consequently, this upward trend in hospitalization rates is set to stimulate the growth of the intravenous fluid transfer drug device market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=19535&type=smp

How Is the Intravenous Fluid Transfer Drug Devices Market Segments Structured?

The intravenous fluid transfer drug devicesmarket covered in this report is segmented –

1) By Type: Infusion Bags, Infusion Devices, Other Types

2) By Application: Autoimmune Diseases, Blood Disorders, Cardiovascular Disorders, Neurology, Oncology, Other Applications

3) By End-Use Sector: Hospitals, Specialized Clinics, Other End-Use Sectors

Subsegments:

1) By Infusion Bags: PVC Infusion Bags, Non-PVC Infusion Bags, Pre-Filled Infusion Bags, Multi-Chamber Infusion Bags, IV Fluid Administration Bags

2) By Infusion Devices: Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Gravity Infusion Devices, Smart Infusion Devices

3) By Other Types: IV Sets And Accessories, IV Catheters, Needleless Connectors, Flow Regulators, Pressure Infusion Devices.

What Strategic Trends Are Transforming the Intravenous Fluid Transfer Drug Devices Market?

In an effort to increase precision, enhance patient safety, and simplify the administration of fluids and medications, leading companies in the intravenous fluid transfer drug device sector are investing in the development of all-inclusive and modular infusion systems that come equipped with auto-identification functions. Auto-identification in these systems autonomously verifies and matches the correct medication to the appropriate patient through RFID technology or barcode scanning. One example is Becton, Dickinson, and Company, a medical device firm based in the U.S., which in July 2023 gained FDA 510(k) clearance for their advanced BD Alaris Infusion System. This updated system incorporates new hardware for its Point-of-Care Unit (PCU), encompassing large capacity pumps, PCA pumps, respiratory monitors, syringe pumps, and auto-identification modules. The system is also outfitted with cutting-edge software that boasts enhanced cybersecurity features and interoperability, allowing for unrestrained integration with popular electronic medical record (EMR) systems supporting smart, connected healthcare.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/intravenous-fluid-transfer-drug-devices-global-market-report

Which Global Regions Offer the Highest Growth in the Intravenous Fluid Transfer Drug Devices Market?

North America was the largest region in the intravenous fluid transfer drug devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19535

This Report Delivers Insight On:

1. How big is the intravenous fluid transfer drug devices market, and how is it changing globally?

2. Who are the major companies in the intravenous fluid transfer drug devices market, and how are they performing?

3. What are the key opportunities and risks in the intravenous fluid transfer drug devices market right now?

4. Which products or customer segments are growing the most in the intravenous fluid transfer drug devices market?

5. What factors are helping or slowing down the growth of the intravenous fluid transfer drug devices market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the intravenous fluid transfer drug devices market?

The intravenous fluid transfer drug devices market has seen consistent growth, increasing from $7.38 billion in 2024 to $7.85 billion in 2025 at a CAGR of 6.4%. Its historical growth was influenced by rising demand for efficient medical supplies, expansion in healthcare infrastructure, more surgical interventions requiring IV support, evolving policy changes, and new drugs requiring precise administration.

What will be the intravenous fluid transfer drug devices market size in the future?

The intravenous fluid transfer drug devices market is set to grow, reaching $9.96 billion by 2029 with a CAGR of 6.1%. Growth will be driven by increasing demand for portable medical devices, higher investments in advanced healthcare technologies, cost-effective solutions, and non-hospital treatment settings. Key trends include smart technology integration, automated IV fluid transfer adoption, enhanced safety features to minimize medication errors, and compatibility with remote monitoring systems.

Get your intravenous fluid transfer drug devices market report here!

https://www.thebusinessresearchcompany.com/report/intravenous-fluid-transfer-drug-devices-global-market-report

What main drivers are fueling expansion in the intravenous fluid transfer drug devices market?

The rising hospitalization rate is projected to boost the growth of the intravenous fluid transfer drug device market. This increase is due to an aging population, chronic illnesses, better diagnostic tools, and advancements in healthcare access. Intravenous fluid transfer systems precisely administer fluids and medications to hospitalized patients. For instance, the American Hospital Association reported in May 2023 that U.S. hospital admissions reached 34,011,386 in 2023, a rise from 33,356,853 in 2022. Therefore, the growing hospitalization rate is expected to propel the intravenous fluid transfer drug device market.

What key areas define the segmentation of the global intravenous fluid transfer drug devices market?

The intravenous fluid transfer drug devicesmarket covered in this report is segmented –

1) By Type: Infusion Bags, Infusion Devices, Other Types

2) By Application: Autoimmune Diseases, Blood Disorders, Cardiovascular Disorders, Neurology, Oncology, Other Applications

3) By End-Use Sector: Hospitals, Specialized Clinics, Other End-Use Sectors

Subsegments:

1) By Infusion Bags: PVC Infusion Bags, Non-PVC Infusion Bags, Pre-Filled Infusion Bags, Multi-Chamber Infusion Bags, IV Fluid Administration Bags

2) By Infusion Devices: Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Gravity Infusion Devices, Smart Infusion Devices

3) By Other Types: IV Sets And Accessories, IV Catheters, Needleless Connectors, Flow Regulators, Pressure Infusion Devices.

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19535&type=smp

Who are the dominant players expanding their reach in the intravenous fluid transfer drug devices market?

Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., 3M Company, Medtronic plc, Becton, Dickinson and Company, Baxter International Inc., B. Braun Holding GmbH & Co. KG, Fresenius Kabi AG, Mindray Medical International Limited, Nipro Corporation, Moog Inc., West Pharmaceutical Services Inc., ICU Medical Inc., Insulet Corporation, Merit Medical Systems Inc., Avanos Medical Inc., Vygon SAS, NxStage Medical Inc., AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Zyno Medical LLC, Sippex, Arcomed AG

How are evolving market trends shaping intravenous fluid transfer drug devices Strategies?

Notable corporations within the intravenous fluid drug transfer device market are innovating modular and all-inclusive infusion systems equipped with auto-identification features to bolster precision, promote safety of patients, and simplify the administration of medications and fluids. These infusion systems have the capability to automatically match and verify medications to the intended patient with either RFID technology or barcode scanning. For instance, in July 2023, Becton, Dickinson, and Company, a company specializing in medical devices from the United States, attained FDA 510(k) approval for the revised version of their BD Alaris Infusion System. This updated version of the BD Alaris Infusion System comprises restructured hardware for its Point-of-Care Unit (PCU), like large volume pumps, syringe pumps, PCA pumps, respiratory monitoring, and auto-identification modules. It further incorporates an upgraded software version that comes with enhanced features for cybersecurity and interoperability, enabling effortless incorporation with prevalent electronic medical record (EMR) systems, thus advocating for digital, interconnected healthcare.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19535

Which regions are emerging as leaders in the intravenous fluid transfer drug devices market?

North America was the largest region in the intravenous fluid transfer drug devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Antiglaucoma Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antiglaucoma-drugs-global-market-report

Drug Device Combination Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-device-combination-global-market-report

Insulin Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What CAGR is Anticipated for the Intravenous Fluid Transfer Drug Devices Market During the Forecast Period, and Why?

The market size for devices used in intravenous fluid transfer drugs has experienced considerable expansion in the preceding years. It is expected to increase from $7.38 billion in 2024 to $7.85 billion in 2025, representing a compound annual growth rate (CAGR) of 6.4%. Factors contributing to the growth during the historic period include a surge in demand for effective medical supply solutions, expansion of healthcare infrastructure, an upsurge in surgeries that necessitate IV assistance, policy modifications, bolstered healthcare infrastructure, and a rise in the introduction of new drugs that require accurate administration.

The market size for drug devices facilitating intravenous fluid transfer is predicted to experience substantial growth within the upcoming years. The market is projected to expand to $9.96 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.1%. The anticipated expansion throughout the forecast period can be linked to an increased demand for portable appliances, enhanced expenditure on high-tech medical tools, surge in the need for economical healthcare options, and growth of non-hospital treatment environments. Notable trends expected within the forecast duration include the integration of intelligent technologies, the uptake of automated intravenous fluid transfer systems, improvements in safety specifications to lessen medication mistakes, and the utilization of devices compatible with remote monitoring systems.

What Factors Are Propelling the Growth of the Intravenous Fluid Transfer Drug Devices Market from 2025 to 2034?

The growth of the intravenous fluid transfer drug device market is predicted to be fuelled by an increasing hospitalization rate. This surge in hospitalizations can be attributed to factors including an aging society, widespread chronic diseases, advancements in diagnostics, easier healthcare access, lifestyle-related ailments, and progression in medical technology. Fluid transfer systems are essential for the meticulous and controlled delivery of fluids and medical treatments directly into a patient’s bloodstream while they are in hospital. For example, a report by the American Hospital Association (AHA), a U.S-based organization that represents hospitals and healthcare networks, showed that in May 2023, the total admissions across all hospitals in the U.S were 34,011,386. This was an increase from the 33,356,853 admissions in the previous year, 2022. Consequently, the uptrend in hospitalizations is set to stimulate the growth of the intravenous fluid transfer drug device market.

Explore Comprehensive Insights Into The Global Intravenous Fluid Transfer Drug Devices Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19535&type=smp

Which Companies Are Poised to Shape the Future of the Intravenous Fluid Transfer Drug Devices Market?

Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., 3M Company, Medtronic plc, Becton, Dickinson and Company, Baxter International Inc., B. Braun Holding GmbH & Co. KG, Fresenius Kabi AG, Mindray Medical International Limited, Nipro Corporation, Moog Inc., West Pharmaceutical Services Inc., ICU Medical Inc., Insulet Corporation, Merit Medical Systems Inc., Avanos Medical Inc., Vygon SAS, NxStage Medical Inc., AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Zyno Medical LLC, Sippex, Arcomed AG

What Are the Latest Innovations and Trends Influencing the Intravenous Fluid Transfer Drug Devices Market?

Notable corporations within the intravenous fluid drug transfer device market are innovating modular and all-inclusive infusion systems equipped with auto-identification features to bolster precision, promote safety of patients, and simplify the administration of medications and fluids. These infusion systems have the capability to automatically match and verify medications to the intended patient with either RFID technology or barcode scanning. For instance, in July 2023, Becton, Dickinson, and Company, a company specializing in medical devices from the United States, attained FDA 510(k) approval for the revised version of their BD Alaris Infusion System. This updated version of the BD Alaris Infusion System comprises restructured hardware for its Point-of-Care Unit (PCU), like large volume pumps, syringe pumps, PCA pumps, respiratory monitoring, and auto-identification modules. It further incorporates an upgraded software version that comes with enhanced features for cybersecurity and interoperability, enabling effortless incorporation with prevalent electronic medical record (EMR) systems, thus advocating for digital, interconnected healthcare.

Secure Your Global Intravenous Fluid Transfer Drug Devices Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/intravenous-fluid-transfer-drug-devices-global-market-report

Which Market Segments Are Driving Strategic Growth and Trends in the Intravenous Fluid Transfer Drug Devices Market?

The intravenous fluid transfer drug devicesmarket covered in this report is segmented –

1) By Type: Infusion Bags, Infusion Devices, Other Types

2) By Application: Autoimmune Diseases, Blood Disorders, Cardiovascular Disorders, Neurology, Oncology, Other Applications

3) By End-Use Sector: Hospitals, Specialized Clinics, Other End-Use Sectors

Subsegments:

1) By Infusion Bags: PVC Infusion Bags, Non-PVC Infusion Bags, Pre-Filled Infusion Bags, Multi-Chamber Infusion Bags, IV Fluid Administration Bags

2) By Infusion Devices: Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Gravity Infusion Devices, Smart Infusion Devices

3) By Other Types: IV Sets And Accessories, IV Catheters, Needleless Connectors, Flow Regulators, Pressure Infusion Devices.

What Regions Are Contributing Significantly to the Growth of the Intravenous Fluid Transfer Drug Devices Market?

North America was the largest region in the intravenous fluid transfer drug devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Definition of the Intravenous Fluid Transfer Drug Devices Market Impacting Future Growth?

Intravenous fluid transfer drug devices are tools used to deliver fluids and medications directly into a patient’s bloodstream via an intravenous line. The device ensures efficient, controlled, and immediate administration of treatments, which is crucial for hydration, medication delivery, and critical care. These devices are designed to prevent contamination of both the medication and the IV fluid, maintaining sterility and reducing the risk of infection.

Browse Through More Similar Reports By The Business Research Company:

Antiglaucoma Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antiglaucoma-drugs-global-market-report

Drug Device Combination Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-device-combination-global-market-report

Insulin Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s Year-End Sale! Get up to 30% off on comprehensive market research reports—limited time only!

2024-2033 Intravenous Fluid Transfer Drug Devices Market: Key Insights on Growth Opportunities

The Business Research Company’s Year-End Sale! Get up to 30% off on comprehensive market research reports—limited time only!

How is the Intravenous Fluid Transfer Drug Devices Market Expected to Expand from 2024 to 2033?

• The intravenous fluid transfer drug devices market size has grown strongly in recent years. It will grow from $6.96 billion in 2023 to $7.38 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%.

• The intravenous fluid transfer drug devices market size is expected to see strong growth in the next few years. It will grow to $9.4 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%.

Get A Free Sample On The Global Intravenous Fluid Transfer Drug Devices Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19535&type=smp

What Influences Are Propelling the intravenous fluid transfer drug devices Market Forward?

• The rising hospitalization rate is expected to propel the growth of the intravenous fluid transfer drug device market going forward._x000D_

• The rising hospitalization rate is driven by an aging population, chronic illnesses, advanced diagnostics, and increased healthcare access, alongside lifestyle-related diseases and medical technology advancements._x000D_

• Fluid transfer systems ensure precise and controlled administration of fluids and medications directly into the bloodstream in hospitalized patients._x000D_

Which Segments Play a Key Role in Understanding the Intravenous Fluid Transfer Drug Devices Market?

1) By Type: Infusion Bags, Infusion Devices, Other Types

2) By Application: Autoimmune Diseases, Blood Disorders, Cardiovascular Disorders, Neurology, Oncology, Other Applications

3) By End-Use Sector: Hospitals, Specialized Clinics, Other End-Use Sectors

Purchase The Global Intravenous Fluid Transfer Drug Devices Market Report Directly And Get A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/intravenous-fluid-transfer-drug-devices-global-market-report

Which Major Market Players Are Propelling the Intravenous Fluid Transfer Drug Devices Market?

Leading companies driving the global intravenous fluid transfer drug devices market include:

• Cardinal Health Inc._x000D_

• 3M Company_x000D_

• Medtronic plc_x000D_

• Becton_x000D_

• Dickinson and Company_x000D_

What Trends Are Coming to the Forefront in the Intravenous Fluid Transfer Drug Devices Market?

• Major companies in the intravenous fluid transfer drug device market are developing modular and comprehensive infusion systems with features such as auto-identification to enhance accuracy, improve patient safety, and streamline the administration of fluids and medications._x000D_

• Auto-identification in infusion systems automatically verifies and matches medications to the correct patient using barcode scanning or RFID technology._x000D_

_x000D_

Which Regions Are Significant to the Growth of the Intravenous Fluid Transfer Drug Devices Market?

North America was the largest region in the intravenous fluid transfer drug devices market in 2023

The Table Of Content For The 2024-2033 Intravenous Fluid Transfer Drug Devices Market: Key Insights on Growth Opportunities Market Include

1. 2024-2033 Intravenous Fluid Transfer Drug Devices Market: Key Insights on Growth Opportunities Market Executive Summary

2. 2024-2033 Intravenous Fluid Transfer Drug Devices Market: Key Insights on Growth Opportunities Market Segments

3. 2024-2033 Intravenous Fluid Transfer Drug Devices Market: Key Insights on Growth Opportunities Market Size And Template Market Growth Rate

4. Key 2024-2033 Intravenous Fluid Transfer Drug Devices Market: Key Insights on Growth Opportunities Market Trends

5. Major 2024-2033 Intravenous Fluid Transfer Drug Devices Market: Key Insights on Growth Opportunities Market Drivers

……

25. Key Mergers And Acquisitions In The 2024-2033 Intravenous Fluid Transfer Drug Devices Market: Key Insights on Growth Opportunities Market

26. Top 2024-2033 Intravenous Fluid Transfer Drug Devices Market: Key Insights on Growth Opportunities Companies

27. 2024-2033 Intravenous Fluid Transfer Drug Devices Market: Key Insights on Growth Opportunities Market Opportunities And Strategies

28. 2024-2033 Intravenous Fluid Transfer Drug Devices Market: Key Insights on Growth Opportunities Market, Conclusions And Recommendations

29. Appendix

Browse Through More Similar Reports By The Business Research Company:

Insulin Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report

Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Acne Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: